Listen to the interview, it explains fully. he actually mentioned higher than 80 percent. But basically the reason that Bisantrene is already a proven drug which was trialled and approved and the new version basically the same as the one before just it is improved so instead of central line - directly to the hearth - it can be administered via IV. But as far as the regulators concerned it is a new drug, so has to go through the same trials as the old one. Its safety and efficacy will not be effected which is already proven just the administration is much better. This is why it has a much higher chance than a new drug (3%).
- Forums
- General
- General Comments / Chat
Listen to the interview, it explains fully. he actually...
-
-
- There are more pages in this discussion • 531 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.67 |
Change
0.040(2.46%) |
Mkt cap ! $287.1M |
Open | High | Low | Value | Volume |
$1.65 | $1.75 | $1.64 | $202.6K | 121.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5619 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.66 | 2986 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5619 | 1.650 |
1 | 5000 | 1.645 |
1 | 1100 | 1.640 |
1 | 12000 | 1.630 |
2 | 4461 | 1.625 |
Price($) | Vol. | No. |
---|---|---|
1.660 | 2986 | 2 |
1.690 | 6754 | 2 |
1.695 | 7597 | 2 |
1.710 | 408 | 2 |
1.730 | 2399 | 1 |
Last trade - 15.17pm 12/09/2024 (20 minute delay) ? |
Featured News
NEWS
Biotech innovator secures $5.5M R&D tax incentive refund – major boost for cutting-edge programs
NEWS
Exceptional lithium assays uncovered at Falcon Lake – expanding mineralisation, big potential ahead
RAC (ASX) Chart |